高位恶性胆道梗阻胆道双支架植入的疗效
DOI: 10.3971/j.issn.1000-8578.2015.05.017
Keywords: 黄疸,高位胆道阻塞,支架,介入治疗,Comparison of High-intensity Focused Ultrasound with Percutaneous Anhydrous Alcohol Locally Injection Guided by Ultrasound on Curing Portal Vein Tumor Thrombosis,Clinical Study on Effectiveness and Method of Chemotherapy with Implantable Port System in Midadvanced Pulmonary Carcinoma,The Interventional Treatment of Malignant Biliary Obstruction by Implantation Stend,The Involvement Treatment of Liver Cancer with Dehydrated Alochol Lump Injects under the Supersonic Guidance (48 Cases),Preoperative Interventional Therapy of Intermediate and Advanced Breast Cancer,Clinical Application of the Esophageal Stenosis and Esophagobronchial Fistula by Treatment with Stent,The Study of GAS in the TACE of Hepatocellular Carcinoma,An Analysis of the Re-obstruction Factors and the Effective Interventional Treatments for Metallic Biliary Stents Placement Patients with Hilar Cholangiocarcinoma,Clinical Research on the Double Ways Combination Chemotherapy of Artery and Vein Treating the Liver Metastatic Tumours,The Analysis of Treatment Results of 161 Cases Advanced Gastroesoghageal Carcinoma were Treated by Endoscopic Treatment,Clinical Analysis of Placement with Covered Self-expanding Metallic Stent for Comcerous Esophageal Stricture and Occlusion
Abstract:
摘要 目的 分析胆道双支架植入联合胆道外引流治疗高位恶性胆道梗阻（malignant high biliary obstruction，MHBO）临床疗效及应用价值。方法 MHBO患者96例，胆道双支架植入联合胆道外引流77例、胆道单支架植入并对侧引流11例、单纯胆道外引流8例；观察术后近、远期疗效。结果 胆道双支架植入联合胆道外引流77例，成功率为80.21%。96例MHBO患者术前总胆红素、直接胆红素、谷丙转氨酶、谷草转氨酶与术后第7、14天比较，差异有统计学意义（P<0.05）；术后第21天胆道双支架植入患者总胆红素下降率（92.56%）明显高于胆道单支架植入并对侧引流和单纯胆道外引流患者（61.53%），差异有统计学意义（P<0.05）。77例胆道双支架植入患者3、6、9、12、15、18、21月生存率分别为98.70%、88.31%、76.62%、46.75%、18.18%、2.6%、1.3%。结论 胆道双支架植入联合胆道外引流治疗MHBO是一种安全有效的方法，不仅能够迅速退黄并恢复肝功能，为肿瘤的进一步治疗赢取了时间，而且能提高患者的生存质量及延长生存期
Full-Text
